I feel better than I have in a very long time
Therefore, patients must continuously use the drug if they want to maintain their weight
Emerging research suggests that GLP-1RAs may also be beneficial in treating conditions like obstructive sleep apnea (Malhotra et al., 2024), osteoarthritis (Bliddal et al., 2024), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis with liver fibrosis (MASH) (Loomba et al., 2024), polycystic ovary syndrome (PCOS) (Szczesnowicz et al., 2023), Alzheimers disease (Liang et al., 2024), Parkinsons disease (Kalinderi et al., 2024), and addiction (Klausen et al., 2022)
Billing may continue during review or fulfillment pauses under the published membership terms
Core Mechanisms of GLP-1 Action 3.1
Additional formats and formulations are under development for future applications